Opus Genetics IRD Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $45.09M+48.7% | $30.32M-40.0% | $50.5M+18.5% | $42.63M+73.8% | ||
| $2M-44.0% | $3.56M+285% | $926K-28.7% | $1.3M— | ||
| $1.79M+247% | $515K-53.1% | $1.1M-24.4% | $1.45M+10.6% | ||
| $50.04M+36.7% | $36.61M-32.1% | $53.95M+10.1% | $48.99M+87.9% | ||
| $199K-21.0% | $252K— | $0-100% | $6K-40.0% | ||
| $50.24M+36.3% | $36.86M-31.7% | $53.95M+10.1% | $48.99M+87.9% | ||
| $3.29M+4.6% | $3.15M+46.2% | $2.15M+101% | $1.07M-32.5% | ||
| $1.99M-75.5% | $8.15M+349% | $1.82M+132% | $782K+60.2% | ||
| $7.78M-31.1% | $11.3M+179% | $4.04M+46.8% | $2.75M-28.6% | ||
| $1.13M— | $0— | —— | —— | ||
| $25.99M+130% | $11.3M+179% | $4.04M+46.8% | $2.75M-28.6% | ||
| $0— | $0— | $0— | $0— | ||
| 125M+4,166,567% | 3K+50.0% | 2K-100.0% | 75M0.0% | ||
| $203.93M+39.9% | $145.72M+10.9% | $131.37M+11.6% | $117.72M+5.5% | ||
| -$188.59M-35.7% | -$139M-70.6% | -$81.47M-14.0% | -$71.48M+20.0% | ||
| $15.35M+128% | $6.72M-86.5% | $49.91M+7.9% | $46.24M+108% | ||
| $50.24M+36.3% | $36.86M-31.7% | $53.95M+10.1% | $48.99M+87.9% | ||
| $1.17M-47.0% | $2.21M+57.0% | $1.41M— | —— | ||
| $1.99M+34.5% | $1.48M+96.7% | $753K-3.7% | $782K+60.2% | ||
| $0— | $0— | —— | —— | ||
| $1.99M+34.5% | $1.48M+96.7% | $753K-3.7% | $782K+60.2% | ||
| $420K-73.9% | $1.61M+172% | $591K+184% | $208K+148% | ||
| $25.99M— | $0— | —— | —— | ||
| $4.49M-44.9% | $8.15M— | —— | —— | ||
| $1.13M— | —— | —— | —— | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 69.9M+121% | 31.6M+31.7% | 24M+14.9% | 20.9M+10.7% | ||
| 10M+0.1% | 10M-0.1% | 10M0.0% | 10M0.0% | ||
| 0— | 0— | 0— | 0— | ||
| 0— | 0— | 0— | 0— | ||
| $7K+133% | $3K+50.0% | $2K0.0% | $2K0.0% | ||
| $0— | $0— | $0— | $0— | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 22.9M+218% | 7.2M— | —— | —— | ||
| $1.31-72.8% | $4.82-100.0% | $6,400,000.00— | —— | ||
| $0— | $0— | —— | —— | ||
| —— | —— | —— | —— | ||
| $420K-73.9% | $1.61M+172% | $591K+184% | $208K+148% | ||
| $2.06M-53.7% | $4.45M+1,013% | $400K— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $00.0% | $00.0% | $00.0% | $00.0% | ||
| $125M0.0% | $125M+66.7% | $75M0.0% | $75M0.0% | ||
| $69.89M+121% | $31.57M+31.7% | $23.98M+14.9% | $20.86M+10.7% | ||
| $69.89M+121% | $31.57M+31.7% | $23.98M+14.9% | $20.86M+10.7% | ||
| $25.99M— | $0— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $15K-97.5% | $606K+754% | $71K-57.5% | $167K+109% | ||
| —— | —— | —— | —— | ||
| $00.0% | $00.0% | $00.0% | $00.0% | ||
| $10M+0.1% | $9.99M-0.1% | $10M0.0% | $10M0.0% | ||
| $0— | $0— | $0— | $0— | ||
| $0— | $0— | $0— | $0— | ||
| $1.31-72.8% | $4.82— | —— | —— | ||
| $22.9M+218% | $7.2M— | —— | —— | ||
| $1.31-72.8% | $4.82— | —— | —— | ||
| 22.9M+218% | 7.2M— | —— | —— | ||
| 0— | 0— | —— | —— | ||
| $25.99M— | —— | —— | $0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Opus Genetics's total assets?
- Opus Genetics (IRD) holds $66.8M in total assets, up 38.7% year over year.
- How much debt does Opus Genetics have?
- Opus Genetics carries $1.2M in total debt against -$45.8M of shareholders' equity, a debt-to-equity ratio of 0.07.
- How much cash does Opus Genetics have?
- Opus Genetics holds $60.0M in cash and equivalents.
- Can Opus Genetics cover its short-term obligations?
- Its current ratio is 7.13 — current assets exceed current liabilities.
- Where does Opus Genetics's balance sheet data come from?
- Every line is extracted from Opus Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
